期刊文献+

肾素前体和成熟肾素的原核表达及纯化

Prokaryotic expression and purification of human renin and mature renin
原文传递
导出
摘要 目的原核表达及纯化肾素前体(renin,REN)和成熟肾素(REN-340),并检测其浓度。方法根据NCBI中检索获得的人REN基因序列(5972),经E.coli密码子优化后,人工合成REN及REN-340基因片段,克隆至载体p ET-28a(+),构建重组表达质粒6×His-REN-p ET和6×His-REN-340-p ET。转化至感受态E.coli BL21(DE3),于不同诱导温度(20、25、30、37℃)及不同终浓度(0.1、0.2、0.4、0.5 mmol/L)IPTG条件下进行诱导表达。采用最佳诱导条件诱导表达重组REN和REN-340,经Ni-NTA镍离子亲和层析后,ELISA法检测其浓度。结果经双酶切及测序鉴定,重组表达质粒6×His-REN-p ET和6×His-REN-340-p ET构建正确。重组REN和REN-340的最佳诱导温度分别为37和20℃,最佳IPTG终浓度分别为0.1和0.2 mmol/L。纯化的重组REN和RNE-340浓度分别为9148.21和15115.31 m IU/m L。结论制备的重组REN和REN-340蛋白浓度较高,且生产周期较短,有望用于制备室间质量评价(external quality assessment,EQA)的候选质控品和标准物质。 Objective To express and purify the human renin(REN)and mature renin(REN-340)in prokaryotic cells,and detect the concentration.Methods According to the human REN gene sequence(5972)registered in NCBI,REN and REN-340 gene fragments were artificially synthesized and cloned into vector pET-28a(+)after E.coli codon optimization,and the recombinant expression plasmids 6×His-REN-pET and 6×His-REN-340-pET were constructed.The recombinant plasmids were transformed into competent E.coli BL21(DE3)and induced at different induction temperatures(20,25,30 and 37 C)and different final concentrations(0.1,0.2,0.4 and 0.5 mmol/L)of IPTG.Recombinant REN and REN-340 were induced under the optimal induction conditions,and the concentrations were detected by ELISA after nickel ion affinity chromatography with Ni-NTA.Results The recombinant expression plasmids 6×His-REN-pET and 6×His-REN-340-pET were constructed correctly as identified by restriction analysis and sequencing.The optimum induction temperature of recombinant REN and REN-340 was 37 C and 20℃,and the best final concentration of IPTG was 0.1 and 0.2 mmol/L,respectively.The concentrations of purified recombinant REN and REN-340 were 9148.21 and 15115.31 mIU/mL,respectively.Conclusion The prepared recombinant REN and REN-340O proteins have high concentration with short production cycle,which are expected to be used as candidate quality control products and standard substances for external quality assessment(EQA).
作者 张超 汪静 李小鹏 张江涛 张传宝 ZHANG Chao;WANG Jing;LI Xiaopeng;ZHANG Jiangtao;ZHANG Chuanbao(National Center for Clinical Laboratories,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing Hospital/National Center of Gerontology,Beijing 100730,China)
出处 《中国生物制品学杂志》 CAS CSCD 北大核心 2023年第12期1471-1475,共5页 Chinese Journal of Biologicals
基金 国家自然科学基金青年项目(82003809) 北京医院“科技新星”项目(BJ-2020-087)。
关键词 肾素前体 成熟肾素 基因重组 原核表达 Renin(REN) Mature renin(REN-340) Gene recombination Prokaryotic expression
  • 相关文献

参考文献1

二级参考文献20

  • 1张炜,汤正义,吴景程,王卫庆,宁光.静脉盐水负荷试验在原发性醛固酮增多症诊断中的应用[J].上海交通大学学报(医学版),2007,27(6):703-705. 被引量:22
  • 2Mosso L, Carvajal C, Gonzdlez A, et al. Primary aldosteronism and hypertensive disease [ J ]. Hypertension, 2003,42 ( 2 ) : 161 -165. DOI : 10.1161/01. HYP. 0000079505. 25750. l 1.
  • 3Calhoun DA. Is there an unrecognized epidemic of primary aldosteronism? Pro [ J ]. Hypertension, 2007, 50 ( 3 ) : 447-453 ; discussion 447-453. DOI: 10. l l61/HYPERTENSIONAHA. 106. 086116.
  • 4Loh KC, Koay ES, Khaw MC, et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore [ J ]. J Clin Eudocrinol Metab, 2000,85 ( 8 ) : 2854-2859. DOI: 10. 1210/ jcem. 85.8. 6752.
  • 5Sang X, Jiang Y, Wang W, et al. Prevalence of and risk factors forprimary aldosteronism among patients with resistant hypertension in China[J]. J Hypertens, 2013,31 (7) : 1465-1471 ; discussion 1471- 1472. DOI: 10. 1097/HJH. 0b013e328360ddf6.
  • 6Di MA, Petramala L, Cotesta D, et al. Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism [ J ]. J Renin Angiotensin Aldosterone Syst, 2010, 11 (3) : 165-172. DOI : 10.1177/1470320310366581.
  • 7Hiramatsu K, Yamada T, Yukimura Y, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients[ J]. Arch Intern Med, 1981, 141(12) :1589-1593.
  • 8Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2008, 93(9) :3266-3281. DOI: 10. 1210/jc. 2008-0104.
  • 9Ahmed AH, Cowley D, Wolley M, et al. Seated saline suppression testing for the diagnosis of primary aldosteronism : a preliminary study [J]. J Clin Endocrinol Metab, 2014, 99 ( 8 ) : 2745-2753. DOI: 10. 1210/jc. 2014-1153.
  • 10Rossi GP, Auchus R J, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism[ J]. Hypertension, 2014, 63 ( 1 ) : 151-160. DOI: 10.1161/HYPERTENSIONAHA. 113. 02097.

共引文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部